Literature DB >> 1779620

Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria.

A G Antoshechkin1, T V Chentsova, D B Naritsin, G P Railian.   

Abstract

By using ion-exchange chromatography and gas chromatography coupled with mass spectrometry, the content of phenylalanine, tyrosine and their metabolites typical of phenylketonuria (PKU) was determined in the cerebrospinal fluid (CSF) of 8 untreated children with classical PKU and 9 controls. At the same time, plasma and urine were analysed. In PKU the content of phenylalanine is increased on average 23 times in plasma and CSF. The content of phenylalanine and tyrosine in CSF is about 4 times less as compared with plasma. The phenylalanine-to-tyrosine ratio is approximately the same for these fluids both in control and in PKU. This indicates that the transport of phenylalanine and tyrosine through the blood-brain barrier is not disturbed in PKU. Phenylpyruvate and 4-hydroxyphenylpyruvate are either not detected or present in very low concentrations in the CSF of children with PKU; their derivatives, phenyllactate and 4-hydroxyphenyllactate, are present in relatively higher concentrations. This indicates increased metabolic conversion in brain tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779620     DOI: 10.1007/bf01799945

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

1.  Screening of amniotic fluid metabolites by gas chromatography-mass spectrometry.

Authors:  A G Antoshechkin; A B Golovkin; L A Maximova; V A Bakharev
Journal:  J Chromatogr       Date:  1989-04-14

2.  The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain.

Authors:  C M McKean; D E Boggs; N A Peterson
Journal:  J Neurochem       Date:  1968-03       Impact factor: 5.372

Review 3.  Brain metabolism: a perspective from the blood-brain barrier.

Authors:  W M Pardridge
Journal:  Physiol Rev       Date:  1983-10       Impact factor: 37.312

4.  Plasma and cerebrospinal fluid amino acid concentrations in phenylketonuria during the newborn period.

Authors:  S E Snyderman; C Sansaricq; P M Norton; J V Castro
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

5.  Serotonin and dopamine synthesis in phenylketonuria.

Authors:  H C Curtius; A Niederwieser; M Viscontini; W Leimbacher; H Wegmann; B Blehova; F Rey; J Schaub; H Schmidt
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

6.  Discovery of methoxyacetylcarbamide in the urine of normal adults and phenylketonuric children.

Authors:  A G Antoshechkin; L A Maximova
Journal:  Clin Chim Acta       Date:  1988-10-31       Impact factor: 3.786

7.  On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.

Authors:  G W Ratzmann; U Grimm; K Jährig; A Knapp
Journal:  Biomed Biochim Acta       Date:  1984

8.  Serotonin and noradrenaline concentrations and serotonin uptake in platelets from hyperphenylalaninaemic patients.

Authors:  M Giovannini; R Valsasina; R Longhi; A M Cesura; M D Galva; E Riva; G P Bondiolotti; G B Picotti
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

9.  Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.

Authors:  H C Lou; F Güttler; C Lykkelund; P Bruhn; A Niederwieser
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

10.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  5 in total

1.  Phenylalanine and other amino acids in phenylketonuria.

Authors:  P C Clemens; J G Burmester; B H Prankel; G Wiegand; A P Wulke; C Plettner
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

2.  Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria.

Authors:  G M Knudsen; S Hasselbalch; P B Toft; E Christensen; O B Paulson; H Lou
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria.

Authors:  Andrew S Davison; Brendan P Norman; Hazel Sutherland; Anna M Milan; James A Gallagher; Jonathan C Jarvis; Lakshminarayan R Ranganath
Journal:  Metabolites       Date:  2022-05-25

4.  1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU).

Authors:  Paul E Sijens; Matthijs Oudkerk; Dirk-Jan Reijngoud; Klaas L Leenders; Harold W de Valk; Francjan J van Spronsen
Journal:  Eur Radiol       Date:  2004-08-03       Impact factor: 5.315

Review 5.  Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?

Authors:  F J van Spronsen; Marieke Hoeksma; Dirk-Jan Reijngoud
Journal:  J Inherit Metab Dis       Date:  2009-01-13       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.